Article

Efgartigimod efficacy and safety in refractory Myasthenia Gravis - UK’s first real-world experience

2024-02-01

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> We report our experience of patients with generalised MG (gMG) treated with Efgartigimod, an FcN antagonist, under the Early Access to Medicine Scheme (EAMS) in the UK. <h4>Methods</h4> Data from all UK patients treated with Efgartigimod under the EAMS June 22-July 23 were collected retrospectively. Efgartigimod was administered as per the ADAPT protocol (consisting of a treat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8be21bd3-693a-5a52-a21f-757c1a23ad97
DOI: 10.1101/2024.01.31.24302082

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efgartigimod efficacy and safety in refractory Myasthenia Gravis - UK’s first real-world experienceDOI 10.1101/2024.01.31.24302082Read

Real-World Case Series of Efgartigimod for Generalized Myasthenia Gravis：Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom ControlSemantic proximity Read

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of its Pharmacological Profile, Clinical Utility, and Expanding ApplicationsSemantic proximity Read

Early Versus Delayed Add-on Therapy in Generalized Myasthenia Gravis: A Multicenter Real-World Cohort StudySemantic proximity Read

Clinical characteristics and outcome of treatment-refractory myasthenia gravis -a retrospective studySemantic proximity Read

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read

A Retrospective Longitudinal Cohort Study of The Clinical Burden in Myasthenia GravisSemantic proximity Read

Early Use of Low Dose Rituximab in Anti Acetylcholine Receptor Generalised Myasthenia Gravis in South Wales – a Retrospective StudySemantic proximity Read

Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell TherapySemantic proximity Read

Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment AdvancementsSemantic proximity Read

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read

Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.Semantic proximity Read

Clinical aspects and serodiagnosis of myasthenia gravis in Algerian patients: a prospective study on a small group of patientsSemantic proximity Read